Cann Group Limited (CNGGF)

Market Cap	6.27M
Revenue (ttm)	9.60M
Net Income (ttm)	-29.46M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	1,232
Open	0.0188
Previous Close	n/a
Day's Range	0.0188 - 0.0188
52-Week Range	0.0050 - 0.0540
Beta	1.33
RSI	45.72
Earnings Date	May 29, 2025

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNGGF

Financial Performance

In 2024, Cann Group's revenue was 18.36 million, a decrease of -11.03% compared to the previous year's 20.63 million. Losses were -51.24 million, 51.6% more than in 2023.

Financial numbers in AUD